SECOND-QUARTER HIGHLIGHTS:
- TOTAL REVENUE UP 5.4%; SAME-UNIT REVENUE UP 2.8%
- GAAP EPS DOWN 26.4%; ADJUSTED EPS DOWN 9.1%; INCLUDES MARCUM
ACQUISITION-RELATED EXPENSE OF $6.7M
- NET INCOME DOWN 26.3%; ADJUSTED EBITDA DOWN 6.9%
SIX-MONTH HIGHLIGHTS:
- TOTAL REVENUE UP 7.2%; SAME-UNIT REVENUE UP 4.4%
- GAAP EPS DOWN 3.0%; ADJUSTED EPS UP 1.5%; INCLUDES MARCUM
ACQUISITION-RELATED EXPENSE OF $6.7M
- NET INCOME DOWN 3.3%; ADJUSTED EBITDA UP 1.0%
CLEVELAND, July 31,
2024 /PRNewswire/ -- CBIZ, Inc., (NYSE: CBZ) ("CBIZ"
or the "Company"), a leading provider of financial, insurance and
advisory services, today announced results for the second quarter
and six months ended June 30,
2024.
In a separate press release issued today, CBIZ also announced it
has entered into a definitive agreement to acquire Marcum LLP
("Marcum"), a national accounting and advisory firm. Upon closing,
CBIZ will become the seventh-largest accounting services provider
in the U.S. The cash-and-stock transaction valued at approximately
$2.3 billion is expected to close in
the fourth quarter. CBIZ incurred approximately $6.7 million in fees related to the Marcum
transaction and results for the second quarter are impacted by
$0.10 per share. The press release
announcing this transaction is available on CBIZ's website at
https://cbiz.gcs-web.com/investor-overview.
Second-Quarter and First-Half 2024 Results
During the
2024 second quarter, CBIZ experienced the departure of a small
group of producers and support staff within our Property and
Casualty business and a loss of clients served by this group.
Included in reported results is the impact of $0.03 in Adjusted earnings per share for the 2024
second quarter and first half. The impact to full-year 2024
Adjusted earnings per share is expected to be approximately
$0.06.
For the 2024 second quarter, CBIZ recorded revenue of
$420.0 million, an increase of
$21.5 million, or 5.4%, compared with
$398.5 million reported for the
same period in 2023. Acquired operations contributed $10.5 million, or 2.6%, to second-quarter 2024
revenue growth. Same-unit revenue increased by $11.0 million, or 2.8%, for the quarter, compared
with the same period a year ago. Net income was $19.8 million, or $0.39 per diluted share, for the quarter,
compared with $26.9 million, or
$0.53 per diluted share, for the same
period a year ago.
For the six months ended June 30, 2024, CBIZ recorded
revenue of $914.3 million, an
increase of $61.2 million, or 7.2%,
over the $853.1 million recorded
for the same period in 2023. Acquired operations contributed
$23.3 million, or 2.7%, to revenue
growth in the six months ended June 30, 2024. Same-unit
revenue increased by $37.9 million,
or 4.4%, for the six months ended June 30,
2024, compared with the same period a year ago. Net income
was $96.7 million, or $1.92 per diluted share, for the six months ended
June 30, 2024, compared with $100.0
million, or $1.98 per diluted
share, for the same period a year ago.
Excluding nonrecurring acquisition-related integration expenses
and professional fees incurred related to the Marcum transaction,
Adjusted net income was $25.0 million
in the second quarter of 2024, compared with Adjusted net income of
$27.6 million for the same period a
year ago. Adjusted earnings per share was $0.50 for the second quarter of 2024, a decrease
of 9.1%, compared with Adjusted earnings per share of
$0.55 for the same period a year ago.
Adjusted EBITDA for the second quarter of 2024 was $50.7 million, down 6.9%, compared with
$54.4 million for the same period in
2023.
For the six months ended June 30,
2024, Adjusted net income was $102.5
million, compared with Adjusted net income of $102.0 million for the same period a year ago.
Adjusted earnings per share was $2.04 for the six months ended June 30,
2024, an increase of 1.5%, compared with Adjusted earnings per
share of $2.01 for the same period a
year ago. Adjusted EBITDA for the six months ended June 30,
2024, was $169.5 million, compared
with $167.8 million for the same
period in 2023.
Schedules reconciling Adjusted net income, Adjusted earnings per
share and Adjusted EBITDA to the most directly comparable GAAP
measures can be found in the tables included at the end of this
release.
The balance outstanding on the Company's unsecured credit
facility on June 30, 2024, was $381.0
million, with $209.8 million
of unused borrowing capacity.
CEO Commentary
Jerry
Grisko, CBIZ President and Chief Executive Officer, said,
"We are pleased to report that our second-quarter results were
generally in line with our expectations and that the overall health
of our business remains strong. At the same time, we did experience
a small number of unique headwinds that impacted our results for
the quarter. Among these headwinds were the exit of a small group
of producers from our Property and Casualty Insurance business and
some evidence of clients delaying investment decisions and
tightening discretionary spending. While our clients remain largely
optimistic about the second half of the year, we find that any
uncertainty in the market is amplified in an election year given
concerns around regulations and interest rates. The nature of our
resilient business model, with a high rate of recurring revenue and
variable expense, enables us to maintain our performance even in
less predictable business conditions."
Grisko continued, "This morning we announced our agreement to
acquire Marcum. After closing, the new, combined business will
solidify our position as a leading provider of professional
services to middle market businesses and is projected to be
accretive to Adjusted Earnings in its first full year of
operations. On a combined basis, we will become the seventh-largest
accounting services provider in the country with revenues of
approximately $2.8 billion, will
employ over 10,000 team members and will serve more than 135,000
clients with a unique breadth of services and depth of expertise,
including Benefits & Insurance services. We are excited about
our future together and the opportunities this will provide to our
people, the solutions we will bring to our clients, and the value
we expect to create for our shareholders."
2024 Outlook
With an expected close in fourth quarter
of 2024, our current guidance excludes the impact of the Marcum
acquisition. Based on expectations for the remainder of 2024, and
due to the projected $0.06 per share
full year impact of the loss of Property and Casualty business, the
Company expects the following:
- Total revenue to grow within a range of 7% to 9% over the prior
year.
- Effective tax rate of approximately 28%.
- Weighted average fully diluted share count of approximately
50.0 to 50.5 million shares.
- GAAP fully diluted earnings per share to grow within a range of
6% to 8%, to $2.53 to $2.58 per share, compared with the $2.39 per share reported for 2023.
- Adjusted fully diluted earnings per share to grow within a
range of 10% to 12%, to $2.64 to
$2.69 per share, compared with the
$2.41 per share reported for
2023.
Conference Call
CBIZ will host a conference call at
11 a.m. (ET) today to discuss its
second-quarter and first-half financial results as well as the
Marcum acquisition announcement. The call will be webcast and an
archived replay will be available at
https://cbiz.gcs-web.com/investor-overview. Participants can
register at https://dpregister.com/sreg/10191052/fd1f3d903c.
About CBIZ
CBIZ is a leading provider of financial,
insurance and advisory services to businesses throughout
the United States. Financial
services include accounting, tax, government health care
consulting, transaction advisory, risk advisory, and valuation
services. Insurance services include employee benefits consulting,
retirement plan consulting, property and casualty insurance,
payroll, and human capital consulting. With more than 120 offices
in 33 states, CBIZ is one of the largest accounting and insurance
brokerage providers in the U.S. For more information, visit
www.cbiz.com.
Forward-Looking Statements
Forward-looking statements
in this release are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those projected. Such risks and uncertainties include, but are
not limited to: we may be more sensitive to revenue fluctuations
than other companies, which could result in fluctuations in the
market price of our common stock; payments on accounts receivable
may be slower than expected, or amounts due on receivables or notes
may not be fully collectible; we are dependent on the services of
our executive officers, other key employees, producers and service
personnel, the loss of whom may have a material adverse effect on
our business, financial condition and results of operations;
restrictions imposed by independence requirements and conflict of
interest rules may limit our ability to provide services to clients
of the attest firms with which we have contractual relationships
and the ability of such attest firms to provide attestation
services to our clients; our goodwill and intangible assets could
become impaired, which could lead to material non-cash charges
against earnings; certain liabilities resulting from acquisitions
are estimated and could lead to a material non-cash impact on
earnings; governmental regulations and interpretations are subject
to changes, which could have a material adverse effect on our
clients, our business, our business services operations, our
business models, or our revenue; changes in the United States healthcare or public health
environment, including new healthcare legislation or regulations,
may adversely affect the revenue and margins in our or our clients'
businesses; we are subject to risks relating to processing customer
transactions for our payroll and other transaction processing
businesses; cyber-attacks or other security breaches involving our
computer systems or the systems of one or more of our vendors or
clients could materially and adversely affect our business; we are
subject to risk as it relates to software that we license from
third parties; we could be held liable for errors and omissions,
contract claims, or other litigation judgments or expenses; the
future issuance of additional shares could adversely affect the
price of our common stock; our principal stockholders may have
substantial control over our operations; we require a significant
amount of cash for interest payments on our debt and to expand our
business as planned; terms of our credit facility may adversely
affect our ability to run our business and/or reduce stockholder
returns; our failure to satisfy covenants in our debt instruments
could cause a default under those instruments; we are reliant on
information processing systems and any failure of these systems
could have a material adverse effect on our business, financial
condition and results of operations; we may not be able to acquire
and finance additional businesses which may limit our ability to
pursue our business strategy; the business services industry is
competitive and fragmented; if we are unable to compete
effectively, our business, financial condition and results of
operations may be negatively impacted; there is volatility in our
stock price.
With respect to the agreement to acquire Marcum, such risks and
uncertainties include, but are not limited to: the ability of the
parties to consummate the transaction in a timely manner or at all;
satisfaction of the conditions precedent to consummation of the
transaction, including the ability to secure regulatory approvals
in a timely manner or at all, and the approval by Marcum's partners
and the approval by the Company's stockholders; the possibility of
litigation related to the transaction and the effects thereof; the
possibility that anticipated benefits and/or synergies of the
transaction will not be achieved in a timely manner or at all; the
possibility that the costs of the transaction and/or liabilities
assumed will be more significant than anticipated; the possibility
that integration will prove more costly and/or time consuming than
anticipated; the possibility that the transaction could disrupt
ongoing plans and operations of the parties or their respective
relationships with clients, other business partners and employees;
the possibility that the financing will not be obtained as
anticipated and the effects of the increased leverage of the
Company following the transaction; and other risks described in the
Company's filings with the Securities and Exchange Commission
("SEC").
Such forward-looking statements can be affected by inaccurate
assumptions we might make or by known or unknown risks and
uncertainties. Should one or more of these risks materialize, or
should the underlying assumptions prove incorrect, actual results
may vary materially from those anticipated, estimated or projected.
Consequently, no forward-looking statements can be guaranteed.
A more detailed description of such risks and uncertainties may
be found in "Item 1A. Risk Factors" of the Company's Annual Report
on Form 10-K for the year ended December 31,
2023, and the Company's other filings with the SEC at
www.sec.gov.
All forward-looking statements made in this release are made
only as of the date hereof. The Company does not undertake any
obligation to publicly update or correct any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as required by law.
ADDITIONAL INFORMATION ABOUT THE TRANSACTION AND WHERE TO
FIND IT
In connection with the transaction with Marcum, the
Company will file a proxy statement with the SEC. The definitive
proxy statement will be mailed to the Company's stockholders and
will contain important information about the transaction and
related matters. THE COMPANY'S STOCKHOLDERS ARE URGED TO READ THE
DEFINITIVE PROXY STATEMENT CAREFULLY WHEN IT BECOMES AVAILABLE
BEFORE MAKING ANY VOTING OR INVESTMENT DECISION WITH RESPECT TO THE
TRANSACTION BECAUSE IT WILL CONTAIN IMPORTANT INFORMATION ABOUT THE
TRANSACTION. The definitive proxy statement and other relevant
materials (when they become available) and any other documents
filed by the Company with the SEC may be obtained free of charge at
the SEC's website at www.sec.gov. In addition, stockholders will be
able to obtain free copies of the definitive proxy statement from
the Company on the Investor Relations page of the Company's
website, www.cbiz.com, or by writing to us at Attention: Investor
Relations Department, 5959 Rockside Woods Blvd. N., Suite 600,
Independence, Ohio 44131.
PARTICIPANTS IN THE SOLICITATION
The Company and its
directors and executive officers may be deemed to be participants
in the solicitation of proxies in connection with the transaction
with Marcum. Information with respect to the Company's directors
and executive officers is set forth in the Company's Proxy
Statement on Schedule 14A for its 2024 Annual Meeting of
Stockholders, which was filed with the SEC on March 25, 2024, and its Annual Report on Form
10-K for the fiscal year ended December 31,
2023, which was filed with the SEC on February 23, 2024. These documents are available
free of charge at the SEC's website at www.sec.gov, or from the
Company on the Investor Relations page of the Company's website,
www.cbiz.com, or by writing to us at Attention: Investor Relations
Department, 5959 Rockside Woods Blvd. N., Suite 600, Independence, Ohio 44131. Additional
information regarding the interests of participants in the
solicitation of proxies in connection with the transaction will be
included in the proxy statement that the Company intends to file
with the SEC.
CBIZ,
INC.
FINANCIAL HIGHLIGHTS
(UNAUDITED)
THREE MONTHS ENDED
JUNE 30, 2024 AND 2023
(In thousands,
except percentages and per share data)
|
|
|
|
Three Months Ended
June 30,
|
|
|
2024
|
|
%
|
|
2023
|
|
%
|
Revenue
|
|
$
420,012
|
|
100.0 %
|
|
$
398,502
|
|
100.0 %
|
Operating expenses
(1)
|
|
366,368
|
|
87.2
|
|
343,987
|
|
86.3
|
Gross
margin
|
|
53,644
|
|
12.8
|
|
54,515
|
|
13.7
|
Corporate general and
administrative expenses (1)
|
|
22,050
|
|
5.2
|
|
15,793
|
|
4.0
|
Operating
income
|
|
31,594
|
|
7.6
|
|
38,722
|
|
9.7
|
Other (expense)
income:
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
(5,884)
|
|
(1.4)
|
|
(5,534)
|
|
(1.4)
|
Other income, net
(1) (2)
|
|
2,483
|
|
0.6
|
|
5,421
|
|
1.4
|
Total other expense,
net
|
|
(3,401)
|
|
(0.8)
|
|
(113)
|
|
—
|
Income before income
tax expense
|
|
28,193
|
|
6.8
|
|
38,609
|
|
9.7
|
Income tax
expense
|
|
8,400
|
|
|
|
11,746
|
|
|
Net
income
|
|
$
19,793
|
|
4.7 %
|
|
$
26,863
|
|
6.7 %
|
|
|
|
|
|
|
|
|
|
Diluted earnings per
share
|
|
$
0.39
|
|
|
|
$
0.53
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted
average common shares outstanding
|
|
50,276
|
|
|
|
50,385
|
|
|
Other
data:
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
(3)
|
|
$
50,683
|
|
|
|
$
54,435
|
|
|
Adjusted EPS
(3)
|
|
$ 0.50
|
|
|
|
$ 0.55
|
|
|
|
|
(1)
|
CBIZ sponsors a
deferred compensation plan, under which a CBIZ employee's
compensation deferral is held in a rabbi trust and invested
accordingly as directed by the employee. Income and expenses
related to the deferred compensation plan are included in
"Operating expenses" and "Corporate general and administrative
expenses," and are directly offset by deferred compensation gains
or losses in "Other expense, net." The deferred compensation plan
has no impact on "Income before income tax
expense."
|
|
|
|
Income and expenses
related to the deferred compensation plan for the three months
ended June 30, 2024, and 2023, are as follows (in
thousands):
|
|
|
Three Months Ended
June 30,
|
|
|
2024
|
|
% of
Revenue
|
|
2023
|
|
% of
Revenue
|
Operating
expense
|
|
$
2,283
|
|
0.5 %
|
|
$
5,102
|
|
1.3 %
|
Corporate general and
administrative expense
|
|
323
|
|
0.1 %
|
|
631
|
|
0.2 %
|
Other income,
net
|
|
2,606
|
|
0.6 %
|
|
5,733
|
|
1.4 %
|
|
|
|
|
Excluding the impact of
the previously mentioned income and expenses related to the
deferred compensation plan, the operating results for the three
months ended June 30, 2024, and 2023, are as follows (in
thousands):
|
|
|
|
|
|
|
Three Months Ended
June 30,
|
|
2024
|
|
2023
|
|
As
Reported
|
|
Deferred
Compensation
Plan
|
|
Adjusted
|
|
% of
Revenue
|
|
As
Reported
|
|
Deferred
Compensation
Plan
|
|
Adjusted
|
|
% of
Revenue
|
Gross margin
|
$
53,644
|
|
$
2,283
|
|
$
55,927
|
|
13.3 %
|
|
$
54,515
|
|
$
5,102
|
|
$
59,617
|
|
15.0 %
|
Operating
income
|
31,594
|
|
2,606
|
|
34,200
|
|
8.1 %
|
|
38,722
|
|
5,733
|
|
44,455
|
|
11.2 %
|
Other income (expense),
net
|
2,483
|
|
(2,606)
|
|
(123)
|
|
— %
|
|
5,421
|
|
(5,733)
|
|
(312)
|
|
(0.1) %
|
Income before income
tax expense
|
28,193
|
|
—
|
|
28,193
|
|
6.8 %
|
|
38,609
|
|
—
|
|
38,609
|
|
9.7 %
|
|
|
(2)
|
Included in "Other
income (expense), net" for the three months ended June 30, 2024,
and 2023, is expense of $0.2 million and $0.8 million,
respectively, related to net changes in the fair value of
contingent consideration related to CBIZ's prior
acquisitions.
|
(3)
|
Refer to the schedules
reconciling Adjusted earnings per share and Adjusted EBITDA to the
most directly comparable GAAP measures at the end of this release,
and for additional information as to the usefulness of the Non-GAAP
financial measures to shareholders and investors.
|
CBIZ,
INC.
FINANCIAL HIGHLIGHTS
(UNAUDITED)
SIX MONTHS ENDED
JUNE 30, 2024 AND 2023
(In thousands,
except percentages and per share data)
|
|
|
|
Six Months Ended
June 30,
|
|
|
2024
|
|
%
|
|
2023
|
|
%
|
Revenue
|
|
$
914,309
|
|
100.0 %
|
|
$
853,108
|
|
100.0 %
|
Operating expenses
(1)
|
|
742,853
|
|
81.2
|
|
684,998
|
|
80.3
|
Gross
margin
|
|
171,456
|
|
18.8
|
|
168,110
|
|
19.7
|
Corporate general and
administrative expenses (1)
|
|
40,761
|
|
4.5
|
|
31,391
|
|
3.7
|
Operating
income
|
|
130,695
|
|
14.3
|
|
136,719
|
|
16.0
|
Other (expense)
income:
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
(10,395)
|
|
(1.1)
|
|
(9,175)
|
|
(1.1)
|
Gain on sale of
operations, net
|
|
—
|
|
—
|
|
99
|
|
—
|
Other income, net
(1) (2)
|
|
11,907
|
|
1.3
|
|
10,533
|
|
1.2
|
Total other income,
net
|
|
1,512
|
|
0.2
|
|
1,457
|
|
0.1
|
Income before income
tax expense
|
|
132,207
|
|
14.5
|
|
138,176
|
|
16.1
|
Income tax
expense
|
|
35,530
|
|
|
|
38,153
|
|
|
Net
income
|
|
96,677
|
|
10.6 %
|
|
100,023
|
|
11.7 %
|
|
|
|
|
|
|
|
|
|
Diluted earnings per
share
|
|
$
1.92
|
|
|
|
$
1.98
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted
average common shares outstanding
|
|
50,248
|
|
|
|
50,639
|
|
|
Other
data:
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
(3)
|
|
$
169,513
|
|
|
|
$
167,783
|
|
|
Adjusted EPS
(3)
|
|
$
2.04
|
|
|
|
$2.01
|
|
|
|
|
(1)
|
CBIZ sponsors a
deferred compensation plan, under which a CBIZ employee's
compensation deferral is held in a rabbi trust and invested
accordingly as directed by the employee. Income and expenses
related to the deferred compensation plan are included in
"Operating expenses" and "Corporate general and administrative
expenses," and are directly offset by deferred compensation gains
or losses in "Other income (expense), net." The deferred
compensation plan has no impact on "Income before income tax
expense."
|
|
|
|
Income and expenses
related to the deferred compensation plan for the six months ended
June 30, 2024, and 2023, are as follows (in thousands):
|
|
|
Six Months Ended
June 30,
|
|
|
2024
|
|
% of
Revenue
|
|
2023
|
|
% of
Revenue
|
Operating
expenses
|
|
$ 10,859
|
|
1.2 %
|
|
$
9,862
|
|
1.2 %
|
Corporate general and
administrative expenses
|
|
1,380
|
|
0.2 %
|
|
1,273
|
|
0.1 %
|
Other income (expense),
net
|
|
12,239
|
|
1.3 %
|
|
11,135
|
|
1.3 %
|
|
|
|
|
|
|
|
|
|
Excluding the impact of
the above-mentioned income and expenses related to the deferred
compensation plan, the operating results for the six months ended
June 30, 2024, and 2023, are as follows (in thousands):
|
|
Six Months Ended
June 30,
|
|
2024
|
|
2023
|
|
As
Reported
|
|
Deferred
Compensation
Plan
|
|
Adjusted
|
|
% of
Revenue
|
|
As
Reported
|
|
Deferred
Compensation
Plan
|
|
Adjusted
|
|
% of
Revenue
|
Gross margin
|
$ 171,456
|
|
$ 10,859
|
|
$ 182,315
|
|
19.9 %
|
|
$ 168,110
|
|
$
9,862
|
|
$ 177,972
|
|
20.9 %
|
Operating
income
|
130,695
|
|
12,239
|
|
142,934
|
|
15.6 %
|
|
136,719
|
|
11,135
|
|
147,854
|
|
17.3 %
|
Other income (expense),
net
|
11,907
|
|
(12,239)
|
|
(332)
|
|
— %
|
|
10,533
|
|
(11,135)
|
|
(602)
|
|
(0.1) %
|
Income before income
tax expense
|
132,207
|
|
—
|
|
132,207
|
|
14.5 %
|
|
138,176
|
|
—
|
|
138,176
|
|
16.1 %
|
|
|
(2)
|
Included in "Other
income (expense), net" for the six months ended June 30, 2024, and
2023, is expense of $0.6 million and $1.4 million, respectively,
related to net changes in the fair value of contingent
consideration related to CBIZ's prior acquisitions.
|
(3)
|
Refer to the financial
highlights tables for a reconciliation of Non-GAAP financial
measures to the most directly comparable GAAP financial measure,
and for additional information as to the usefulness of the Non-GAAP
financial measures to shareholders and investors.
|
CBIZ,
INC.
FINANCIAL HIGHLIGHTS
(UNAUDITED)
(In
thousands)
SELECT SEGMENT
DATA
|
|
|
|
Three Months Ended
June 30,
|
|
Six Months Ended
June 30,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Revenue
|
|
|
|
|
|
|
|
|
Financial
Services
|
|
$ 309,233
|
|
$ 290,930
|
|
$ 681,863
|
|
$ 634,016
|
Benefits and Insurance
Services
|
|
97,419
|
|
95,838
|
|
205,827
|
|
195,892
|
National
Practices
|
|
13,360
|
|
11,734
|
|
26,619
|
|
23,200
|
Total
|
|
$
420,012
|
|
$
398,502
|
|
$
914,309
|
|
$
853,108
|
|
|
|
|
|
|
|
|
|
Gross
Margin
|
|
|
|
|
|
|
|
|
Financial
Services
|
|
$
46,424
|
|
$
47,485
|
|
$ 153,493
|
|
$ 146,128
|
Benefits and Insurance
Services
|
|
14,176
|
|
17,464
|
|
38,947
|
|
40,595
|
National
Practices
|
|
1,332
|
|
1,189
|
|
2,658
|
|
2,072
|
Operating expenses -
unallocated (1):
|
|
|
|
|
|
|
|
|
Other
expense
|
|
(6,005)
|
|
(6,521)
|
|
(12,783)
|
|
(10,823)
|
Deferred
compensation
|
|
(2,283)
|
|
(5,102)
|
|
(10,859)
|
|
(9,862)
|
Total
|
|
$
53,644
|
|
$
54,515
|
|
$
171,456
|
|
$
168,110
|
|
|
(1)
|
Represents operating
expenses not directly allocated to individual businesses, including
stock-based compensation, consolidation and integration charges,
and certain advertising expenses. "Operating expenses -
unallocated" also includes gains or losses attributable to the
assets held in a rabbi trust associated with the Company's deferred
compensation plan. These gains or losses do not impact "Income
before income tax expense" as they are directly offset by the same
adjustment to "Other income (expense), net" in the Consolidated
Statements of Comprehensive Income. Net gains or losses recognized
from adjustments to the fair value of the assets held in the rabbi
trust are recorded as compensation expense (income) in "Operating
expenses" and "Corporate, general and administrative expenses," and
offset in "Other income (expense), net."
|
CBIZ,
INC.
SELECT CASH FLOW
DATA (UNAUDITED)
(In
thousands)
|
|
|
|
Six Months Ended
June 30,
|
|
|
2024
|
|
2023
|
Net
income
|
|
$
96,677
|
|
$
100,023
|
Adjustments to
reconcile net income to net cash provided by operating
activities:
|
|
|
|
|
Depreciation and
amortization expense
|
|
19,008
|
|
17,831
|
Gain on sale of
operations, net
|
|
—
|
|
(99)
|
Bad debt expense, net
of recoveries
|
|
1,244
|
|
805
|
Adjustments to
contingent earnout liability, net
|
|
638
|
|
1,445
|
Stock-based
compensation expense
|
|
5,016
|
|
6,619
|
Other noncash
adjustments
|
|
3,401
|
|
4,671
|
Net income, after
adjustments to reconcile net income to net cash provided by
operating activities
|
|
125,984
|
|
131,295
|
Changes in assets and
liabilities, net of acquisitions and divestitures
|
|
(101,545)
|
|
(101,566)
|
Net cash provided by
operating activities
|
|
24,439
|
|
29,729
|
Net cash used in
investing activities
|
|
(33,247)
|
|
(65,617)
|
Net cash (used in)
provided by financing activities
|
|
(11,920)
|
|
21,793
|
Net decrease in
cash, cash equivalents and restricted cash
|
|
(20,728)
|
|
(14,095)
|
Cash, cash equivalents
and restricted cash at beginning of year
|
|
$
157,148
|
|
$
160,145
|
Cash, cash
equivalents and restricted cash at end of period
|
|
$
136,420
|
|
$
146,050
|
|
|
|
|
|
Reconciliation of
cash, cash equivalents and restricted cash to the consolidated
balance sheet:
|
Cash and cash
equivalents
|
|
$
1,128
|
|
$
3,692
|
Restricted
cash
|
|
44,947
|
|
52,314
|
Cash equivalents
included in funds held for clients
|
|
90,345
|
|
90,044
|
Total cash, cash
equivalents and restricted cash
|
|
$
136,420
|
|
$
146,050
|
CBIZ,
INC.
SELECT FINANCIAL
DATA AND RATIOS (UNAUDITED)
(In
thousands)
|
|
|
|
June 30,
2024
|
|
December 31,
2023
|
Cash and cash
equivalents
|
|
1,128
|
|
8,090
|
Restricted
cash
|
|
44,947
|
|
30,362
|
Accounts receivable,
net
|
|
477,841
|
|
380,152
|
Current assets before
funds held for clients
|
|
562,808
|
|
453,499
|
Funds held for
clients
|
|
131,128
|
|
159,186
|
Goodwill and other
intangible assets, net
|
|
1,035,148
|
|
1,008,604
|
|
|
|
|
|
Total
assets
|
|
2,160,805
|
|
2,043,592
|
|
|
|
|
|
Current liabilities
before client fund obligations
|
|
336,140
|
|
352,028
|
Client fund
obligations
|
|
131,623
|
|
159,893
|
Total long-term debt,
net
|
|
379,660
|
|
310,826
|
|
|
|
|
|
Total
liabilities
|
|
1,269,371
|
|
1,251,974
|
|
|
|
|
|
Treasury
stock
|
|
(910,322)
|
|
(899,093)
|
|
|
|
|
|
Total stockholders'
equity
|
|
891,434
|
|
791,618
|
|
|
|
|
|
Debt to
equity
|
|
42.6 %
|
|
39.3 %
|
Days sales outstanding
(DSO) (1)
|
|
95
|
|
78
|
|
|
|
|
|
Shares
outstanding
|
|
50,162
|
|
49,814
|
Basic weighted average
common shares outstanding
|
|
50,079
|
|
49,989
|
Diluted weighted
average common shares outstanding
|
|
50,248
|
|
50,557
|
|
|
(1)
|
DSO is provided for
continuing operations and represents accounts receivable, net, at
the end of the period, divided by trailing twelve months daily
revenue. The Company has included DSO data because such data is
commonly used as a performance measure by analysts and investors
and as a measure of the Company's ability to collect on receivables
in a timely manner. DSO should not be regarded as an alternative or
replacement to any measurement of performance under GAAP. DSO on
June 30, 2023, was 94.
|
CBIZ,
INC.
GAAP
RECONCILIATION
Net Income and
Diluted Earnings Per Share ("EPS") to Adjusted Net Income, EPS and
EBITDA(1)
(Unaudited.
Amounts in thousands, except per share data)
|
|
|
Three Months Ended
June 30,
|
|
2024
|
|
2023
|
|
Amounts
|
|
EPS
|
|
Amounts
|
|
EPS
|
Net
income
|
$
19,793
|
|
$
0.39
|
|
$
26,863
|
|
$
0.53
|
Adjustments:
|
|
|
|
|
|
|
|
Integration &
retention costs related to acquisitions (2)
|
330
|
|
0.01
|
|
865
|
|
0.03
|
Facility optimization
costs (3)
|
85
|
|
—
|
|
221
|
|
—
|
Transaction costs
(4)
|
6,651
|
|
0.13
|
|
—
|
|
—
|
Income tax effect
related to adjustments
|
(1,906)
|
|
(0.03)
|
|
(330)
|
|
(0.01)
|
Adjusted net
income
|
$
24,953
|
|
$
0.50
|
|
$
27,619
|
|
$
0.55
|
Interest
expense
|
$
5,884
|
|
|
|
$
5,534
|
|
|
Income tax
expense
|
8,400
|
|
|
|
11,746
|
|
|
Tax effect related to
the adjustments above
|
1,906
|
|
|
|
330
|
|
|
Depreciation
|
3,520
|
|
|
|
3,116
|
|
|
Amortization
|
6,020
|
|
|
|
6,090
|
|
|
Adjusted
EBITDA
|
$
50,683
|
|
|
|
$
54,435
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended
June 30,
|
|
2024
|
|
2023
|
|
Amounts
|
|
EPS
|
|
Amounts
|
|
EPS
|
Net
income
|
$
96,677
|
|
$
1.92
|
|
$
100,023
|
|
$
1.98
|
Adjustments:
|
|
|
|
|
|
|
|
Transaction costs
related to acquisitions (2)
|
—
|
|
—
|
|
611
|
|
0.01
|
Integration &
retention costs related to acquisitions (2)
|
912
|
|
0.02
|
|
1,868
|
|
0.04
|
Facility optimization
costs (3)
|
340
|
|
0.01
|
|
221
|
|
—
|
Transaction costs
(4)
|
6,651
|
|
0.13
|
|
—
|
|
—
|
Income tax effect
related to adjustments
|
(2,124)
|
|
(0.04)
|
|
(746)
|
|
(0.02)
|
Adjusted net
income
|
$
102,456
|
|
$
2.04
|
|
$
101,977
|
|
$
2.01
|
Interest
expense
|
$ 10,395
|
|
|
|
$
9,175
|
|
|
Income tax
expense
|
35,530
|
|
|
|
38,153
|
|
|
Gain on sale of
operations, net
|
—
|
|
|
|
(99)
|
|
|
Tax effect related to
the adjustments above
|
2,124
|
|
|
|
746
|
|
|
Depreciation
|
7,043
|
|
|
|
6,091
|
|
|
Amortization
|
11,965
|
|
|
|
11,740
|
|
|
Adjusted
EBITDA
|
$
169,513
|
|
|
|
$
167,783
|
|
|
|
|
(1)
|
CBIZ reports its
financial results in accordance with GAAP. This table reconciles
Adjusted net income, Adjusted EPS, and Adjusted EBITDA to the most
directly comparable GAAP financial measures, "Net income" and
"Diluted earnings per share." Adjusted net income, Adjusted EPS and
Adjusted EBITDA are not defined by GAAP and should not be regarded
as an alternative or replacement to any financial information
determined under GAAP. Adjusted net income, Adjusted EPS and
Adjusted EBITDA exclude significant non-operating related gains and
losses that management does not consider on-going in nature. These
Non-GAAP financial measures are used by the Company as performance
measures to evaluate, assess and benchmark the Company's
operational results and to evaluate results relative to employee
compensation targets. Accordingly, the Company believes the
presentation of these Non-GAAP financial measures allows its
stockholders, debt holders, and other interested parties to
meaningfully compare the Company's period-to-period operating
results.
|
(2)
|
These costs include,
but are not limited to, certain consulting, technology, personnel,
as well as other first year operating and general administrative
costs that are non-recurring in nature. Amounts reported in 2024
related to the costs incurred related to the acquisitions of
Erickson, Brown & Kloster, LLC and CompuData, Inc., and those
reported in 2023 related to the acquisition of Somerset CAPs and
Advisors.
|
(3)
|
These costs relate to
incremental non-recurring lease expense incurred as a result of
CBIZ's real estate optimization efforts.
|
(4)
|
These costs include,
but are not limited to, certain non-recurring legal and other
professional service costs incurred in connection with the
announced purchase of Marcum.
|
CBIZ,
INC.
GAAP
RECONCILIATION
Full Year 2024
Diluted Earnings Per Share ("EPS") Guidance to Full Year 2024
Adjusted Diluted EPS (1)
|
|
|
Full Year 2024
Guidance
|
|
Low
|
|
High
|
Diluted EPS - GAAP
Guidance
|
$
2.53
|
|
$
2.58
|
Adjustments:
|
|
|
|
Integration &
retention costs related to acquisitions (2)
|
0.01
|
|
0.01
|
Transaction costs
(3)
|
0.10
|
|
0.10
|
Adjusted Diluted EPS
Guidance
|
$
2.64
|
|
$
2.69
|
|
|
|
|
GAAP Diluted EPS for
2023
|
$
2.39
|
|
$
2.39
|
Adjusted Diluted EPS
for 2023
|
$
2.41
|
|
$
2.41
|
GAAP Diluted EPS
Range
|
6 %
|
|
8 %
|
Adjusted Diluted EPS
Range
|
10 %
|
|
12 %
|
|
|
(1)
|
The full year 2024
guidance is based on management's current expectations for the
remainder of 2024, excluding the impact of the announced
acquisition of Marcum. Management expects to update guidance for
the combined business upon closing of the transaction, which is
expected to occur in the fourth quarter, subject to the
satisfaction of various closing conditions, including the approval
of the Company's stockholders.
|
(2)
|
These costs include,
but are not limited to, certain non-recurring consulting,
technology, personnel, and other first year operating and general
administrative costs incurred related to the acquisitions of
Erickson, Brown & Kloster, LLC and CompuData, Inc.
|
(3)
|
These costs include,
but are not limited to, certain non-recurring legal and other
professional service costs incurred in connection with the
announced purchase of Marcum.
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cbiz-reports-second-quarter-and-first-half-2024-results-and-announces-agreement-to-acquire-marcum-302210559.html
SOURCE CBIZ, Inc.